SURVYR

EHC

Encompass Health
$122.09
+$0.56 (0.46%)Oct 28 close
Health CareS&P 400 CompareTechnicals
1M3M6M1Y2Y
-26%-16%-6%+5%+15%Oct 2025Oct 2026Apr 202652w high $127.8752w low $93.31
EHCSPY
Wall St. Highest PT $166.82 (+36.6%) Wall St. Avg PT $136.74 (+12.0%)
$93$113$133$152$172POC $107Hi $167Avg $137
Underwater Drawdown %Max DD -26.1%Current -4.5%
0.0%-26.1%
Relative Strength vs SPY-17.2% vs SPYUnderperforming
+37%0%-37%
1W
+$0.38 (0.31%)
1M
−$1.72 (1.39%)
3M
+$8.49 (7.47%)
6M
+$19.85 (19.41%)
YTD
+$16.73 (15.88%)
1Y
−$3.26 (2.60%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for EHC
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

52-week range$93.31 – $127.87

What they do

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients.

Healthcare · Medical Care Facilities
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
40th percentile in sector
C-
12-1 return: +7.3%
Percentile within its GICS sector across the S&P 1500.
Growth
56th percentile in sector
B-
Revenue growth (YoY): +9.6%
Percentile within its GICS sector across the S&P 1500.
Value
58th percentile in sector
B-
Forward E/P: 5.2% · EBITDA/EV: 9.0%
Percentile within its GICS sector across the S&P 1500.
Profitability
71st percentile in sector
B
Profit margin: +10.0% · Return on equity: +25.0%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

Next report: –
No EPS history available.

News & catalysts

More news
Encompass Health (EHC) files 8-K: results, Reg FD disclosure
SEC 8-K · 3h ago
Encompass Health reports results for third quarter 2026
PR Newswire · 3h ago
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
Zacks · Oct 27
Encompass Health declares dividend on common stock
PR Newswire · Oct 22
Insider trades
Darby John Patrick
EVP, Gen Counsel & Secretary · 2026-08-31
Sell
$588.3K
Price Andrew L
Chief Accounting Officer · 2026-08-31
Sell
$630.2K
Darby John Patrick
EVP, Gen Counsel & Secretary · 2026-08-10
Sell
$1.1M
Tarr Mark J
Director, President & CEO · 2026-08-10
Sell
$199.0K
Tarr Mark J
Director, President & CEO · 2026-08-10
Sell
$21.5M
Coltharp Douglas E
EVP & Chief Financial Officer · 2026-08-10
Sell
$2.4M
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed – ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026